SequelSEC

Envoy Medical, Inc. COCH

Orthopedic, Prosthetic & Surgical Appliances & Supplies · CIK 0001840877 · Fiscal year ends 1231

Revenue
$207.00K
Fiscal year ended 2026-06-30
Operating income
-$23.62M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$12.70MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-12-31
Float per share$0.17Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue52.7×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-12-31, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Orthopedic, Prosthetic & Surgical Appliances & Supplies filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
FCF margin-7626.6%0th
Gross margin-262.7%0th
Net margin-9857.3%0th
Operating margin-9240.7%0th
R&D / revenue5180.9%100th
Current ratio0.54x4th
CapEx / revenue74.3%95th
SBC / revenue272.6%95th
Revenue YoY growth7.1%55th

Envoy Medical, Inc. (COCH) reported revenue of $207.00K and net income of -$23.40M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Envoy Medical, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Orthopedic, Prosthetic & Surgical Appliances & Supplies.

Income

Envoy Medical, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$207.00K
Cost of revenue$1.00M
Gross profit-$798.00K
Operating income-$23.62M
Net income-$23.40M
Research & development$14.03M
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrative$8.80M
General & administrative$7.95M
Selling & marketing$846.00K

Balance

Envoy Medical, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalentsUnavailable
Total assets$23.95M
Current assets$21.92M
Total liabilities$20.26M
Current liabilities$12.63M
Total equity incl. NCI$3.30M
Temporary (mezzanine) equity$391.00K
Inventory$1.58M
Accounts receivable$49.00K
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$2.04M

Cash flow

Envoy Medical, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$21.53M
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow$36.11M
Net change in cash$14.39M
Stock-based compensation$804.00K
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

Envoy Medical, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin-385.5%
Operating margin-11411.1%
FCF marginUnavailable
SBC / revenue388.4%
Current ratio1.73x
Revenue YoY growth-6.8%
Net margin-11304.8%
R&D / revenue6776.3%
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open COCH in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-10View SEC filing
10-Q · Filed 2026-05-11View SEC filing
10-K · Filed 2026-03-23View SEC filing
10-Q · Filed 2025-11-10View SEC filing
10-Q · Filed 2025-07-31View SEC filing
10-Q · Filed 2025-05-01View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.